newsfilter
← Latest News
Business Wire·

Ambrx Biopharma Inc. Appoints Daniel O'Connor as Chief Executive Officer

​Ambrx Biopharma Inc., or Ambrx, (NYSE:AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced the